Castelnuovo Barbara, Nanyonjo Agnes, Kamya Moses, Ocama Ponsiano
Infectious Diseases Institute, Kampala, Uganda.
Afr Health Sci. 2008 Jun;8(2):133-4.
In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
We describe here a case of a 60 year old female that experienced a relapse of symptomatic hyperlactatemia after being switched from stavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
This case shows that switching to zidovudine potentially can lead to a hyperlactatemia relapse. Therefore we recommend close follow up for patients that are switched from stavudine to zidovudine and, in case lactate measurement is not possible, free programs should provide safer drugs such as abacavir and tenofovir for patients that develop hyperlactatemia.
在资源有限的环境中,接受抗逆转录病毒治疗且出现司他夫定诱导的高乳酸血症的患者,通常会根据已发表的研究结果转而使用齐多夫定,这些研究表明该药物可以作为一种安全的替代药物。
我们在此描述一名60岁女性的病例,该患者在从司他夫定换用齐多夫定后出现有症状的高乳酸血症复发,以及该病例在乌干达坎帕拉传染病研究所的处理情况。
该病例表明,换用齐多夫定可能会导致高乳酸血症复发。因此,我们建议对从司他夫定换用齐多夫定的患者进行密切随访,并且在无法进行乳酸测量的情况下,免费项目应为出现高乳酸血症的患者提供更安全的药物,如阿巴卡韦和替诺福韦。